v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Net revenue $ 1,224,509 $ 1,102,321
Cost of sales (exclusive of amortization shown separately below) 499,620 493,353
Amortization of acquired intangible assets 7,670 8,908
Total cost of sales 507,290 502,261
Gross profit 717,219 600,060
Operating Expenses    
Selling, general, and administrative 238,979 222,874
Research and development 79,524 75,710
Amortization of acquired intangible assets 11,404 12,479
Total operating expenses 329,907 311,063
Income from operations 387,312 288,997
Other income (loss), net:    
Interest (expense) income, net (1,661) (14,957)
Gain (loss) attributable to equity method investments (note 5) 963 (3,895)
Gain (loss) on equity investments (note 5) (680) (602)
Other, net (2,437) 2,648
Total other income (loss), net (3,815) (16,806)
Income before income taxes 383,497 272,191
Income taxes 72,142 52,769
Net income $ 311,355 $ 219,422
Basic earnings per share (in dollars per share) $ 2.12 $ 1.49
Diluted earnings per share (in dollars per share) 2.11 1.49
Dividend declared per share (in dollars per share) $ 0.53 $ 0.48
Basic shares outstanding (000's) (in shares) 146,861 147,075
Diluted shares outstanding (000's) (in shares) 147,599 147,486
Total Sleep and Breathing Health    
Net revenue $ 1,067,737 $ 963,037
Cost of sales (exclusive of amortization shown separately below) 451,312 444,460
Amortization of acquired intangible assets 1,210 1,916
Residential Care Software    
Net revenue 156,772 139,284
Cost of sales (exclusive of amortization shown separately below) 48,308 48,893
Amortization of acquired intangible assets $ 6,460 $ 6,992

Source